Bugwesa Z Katale, Sylvia Rofael, Linzy Elton, Erasto V Mbugi, Stella G Mpagama, Daphne Mtunga, Maryjesca G Mafie, Peter M Mbelele, Charlotte Williams, Happiness C Mvungi, Rachel Williams, Gulinja A Saku, Joanitha A Ruta, Timothy D McHugh, Mecky I Matee
BACKGROUND: Whole-genome sequencing (WGS)-based prediction of drug resistance in Mycobacterium tuberculosis has the potential to guide clinical decisions in the design of optimal treatment regimens. METHODS: We utilized WGS to investigate drug resistance mutations in a 32-year-old Tanzanian male admitted to Kibong'oto Infectious Diseases Hospital with a history of interrupted multidrug-resistant tuberculosis treatment for more than three years. Before admission, he received various all-oral bedaquiline-based multidrug-resistant tuberculosis treatment regimens with unfavourable outcomes...
August 22, 2024: Annals of Clinical Microbiology and Antimicrobials